| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/02770903.2015.1087556 |
| P698 | PubMed publication ID | 26325232 |
| P2093 | author name string | Fumiko Kasuga | |
| Kazuhisa Takahashi | |||
| Jun Ito | |||
| Yoko Katsura | |||
| Norihiro Harada | |||
| Fumihiko Makino | |||
| Yukinari Itoigawa | |||
| Ryo Atsuta | |||
| Sonoko Harada | |||
| Ayako Ishimori | |||
| P2860 | cites work | Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial | Q24655820 |
| Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group | Q28371563 | ||
| NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response | Q30454236 | ||
| Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial | Q32156400 | ||
| Survey on the impact of comorbid allergic rhinitis in patients with asthma | Q33265227 | ||
| Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function | Q34273804 | ||
| Increased nitric oxide in exhaled air of asthmatic patients | Q34321842 | ||
| Use of exhaled nitric oxide measurements to guide treatment in chronic asthma | Q34421179 | ||
| The role of leukotrienes in airway inflammation | Q34572579 | ||
| The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial | Q34627601 | ||
| Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission | Q35537520 | ||
| Budesonide once versus twice-daily administration: meta-analysis. | Q35990847 | ||
| Treatment of asthma with antileukotrienes: first line or last resort therapy? | Q36410660 | ||
| Epithelially derived endothelin and nitric oxide in asthma | Q40402536 | ||
| Role of regular treatment with inhaled corticosteroid or leukotriene receptor antagonist in mild intermittent asthma | Q42171996 | ||
| Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped down | Q42682069 | ||
| Down-titration from high-dose combination therapy in asthma: Removal of long-acting beta(2)-agonist | Q43079577 | ||
| Effects of pranlukast, a leukotriene receptor antagonist, on airway inflammation in mild asthmatics | Q43546448 | ||
| Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients | Q43604746 | ||
| Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone | Q44027151 | ||
| Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children | Q44162562 | ||
| Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma | Q44615111 | ||
| Asthma control can be maintained after fixed-dose, budesonide/ formoterol combination inhaler therapy is stepped down from medium to low dose | Q45361429 | ||
| Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma | Q46309541 | ||
| Fluticasone given once versus twice a day: meta-analysis. | Q46432064 | ||
| Maintaining asthma control in persistent asthma: comparison of three strategies in a 6-month double-blind randomised study. | Q46497594 | ||
| High fractional concentration of nitric oxide in exhaled air despite steroid treatment in asthmatic children | Q47766190 | ||
| Allergic rhinitis and asthma ad hoc survey: clinical and psychological perspectives. | Q48470763 | ||
| Leukotriene antagonists as first-line or add-on asthma-controller therapy. | Q48679001 | ||
| Fraction of exhaled nitric oxide at 50 mL/s: reference values for adult lifelong never-smokers. | Q50776015 | ||
| Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. | Q51641626 | ||
| Asthma Treatment Guidelines Meet the Real World | Q53473777 | ||
| NO in Exhaled Air of Asthmatic Children Is Reduced by the Leukotriene Receptor Antagonist Montelukast | Q57638323 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pranlukast | Q7238392 |
| P304 | page(s) | 207-212 | |
| P577 | publication date | 2015-09-01 | |
| P1433 | published in | Journal of Asthma | Q2603603 |
| P1476 | title | Evaluation of switching low-dose inhaled corticosteroid to pranlukast for step-down therapy in well-controlled patients with mild persistent asthma. | |
| P478 | volume | 53 |
| Q38903489 | Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma | cites work | P2860 |
Search more.